Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Ueki

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2011
Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cellsAkira Watanabe, Hideki Ogiwara, Shogo Ehata, et al.
European Journal of Endocrinology|October 26, 2020
Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case reportTeruo Jojima, Takahiko Kogai, Toshie Iijima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumorsKeisuke Ueki, Ryo Nishikawa, Yoichi Nakazato, et al.
Endocrine Journal|October 31, 2002
A kindred of familial acromegaly without evidence for linkage to MEN-1 locusYoshiaki Tamura, Shun Ishibashi, Takanari Gotoda, et al.
Cancer Science|October 5, 2021
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trialYoshitaka Narita, Yoshihiro Muragaki, Naoki Kagawa, et al.
Neurologia Medico-Chirurgica|December 3, 2013
A Multicenter Phase I/II Study of the BCNU Implant (Gliadel<sup>®</sup> Wafer) for Japanese Patients with Malignant GliomasTomokazu Aoki, Ryo Nishikawa, Kazuhiko Sugiyama, et al.
Neurologia Medico-Chirurgica|April 18, 2014
A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomasTomokazu Aoki, Ryo Nishikawa, Kazuhiko Sugiyama, et al.
Acta Neuropathologica Communications|March 9, 2017
Genetic and epigenetic stability of oligodendrogliomas at recurrenceKoki Aihara, Akitake Mukasa, Genta Nagae, et al.
Cancer Immunology Research|May 16, 2019
Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in GliomaTakahide Nejo, Hirokazu Matsushita, Takahiro Karasaki, et al.
Acta Neuropathologica|August 31, 2017
Distinct molecular profile of diffuse cerebellar gliomasMasashi Nomura, Akitake Mukasa, Genta Nagae, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2011
Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cellsAkira Watanabe, Hideki Ogiwara, Shogo Ehata, et al.
European Journal of Endocrinology|October 26, 2020
Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case reportTeruo Jojima, Takahiko Kogai, Toshie Iijima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumorsKeisuke Ueki, Ryo Nishikawa, Yoichi Nakazato, et al.
Endocrine Journal|October 31, 2002
A kindred of familial acromegaly without evidence for linkage to MEN-1 locusYoshiaki Tamura, Shun Ishibashi, Takanari Gotoda, et al.
Cancer Science|October 5, 2021
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trialYoshitaka Narita, Yoshihiro Muragaki, Naoki Kagawa, et al.
Neurologia Medico-Chirurgica|December 3, 2013
A Multicenter Phase I/II Study of the BCNU Implant (Gliadel<sup>®</sup> Wafer) for Japanese Patients with Malignant GliomasTomokazu Aoki, Ryo Nishikawa, Kazuhiko Sugiyama, et al.
Neurologia Medico-Chirurgica|April 18, 2014
A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomasTomokazu Aoki, Ryo Nishikawa, Kazuhiko Sugiyama, et al.
Acta Neuropathologica Communications|March 9, 2017
Genetic and epigenetic stability of oligodendrogliomas at recurrenceKoki Aihara, Akitake Mukasa, Genta Nagae, et al.
Cancer Immunology Research|May 16, 2019
Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in GliomaTakahide Nejo, Hirokazu Matsushita, Takahiro Karasaki, et al.
Acta Neuropathologica|August 31, 2017
Distinct molecular profile of diffuse cerebellar gliomasMasashi Nomura, Akitake Mukasa, Genta Nagae, et al.
Pageof 7